{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:14:44Z","timestamp":1766524484380,"version":"3.48.0"},"reference-count":56,"publisher":"BMJ","issue":"7080","license":[{"start":{"date-parts":[[1997,2,22]],"date-time":"1997-02-22T00:00:00Z","timestamp":856569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1997,2,22]]},"DOI":"10.1136\/bmj.314.7080.579","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T19:45:20Z","timestamp":1319744720000},"page":"579","source":"Crossref","is-referenced-by-count":6,"title":["Recent advances: HIV infection-II"],"prefix":"10.1136","volume":"314","author":[{"given":"Claire","family":"Beiser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1997,2,22]]},"reference":[{"key":"2025122313122201000_314.7080.579.1","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1097\/00002030-199312000-00005","article-title":"The mortality and pathology of HIV infection in a West African city.","volume":"7","author":"Lucas","year":"1993","journal-title":"AIDS"},{"key":"2025122313122201000_314.7080.579.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91287-4"},{"key":"2025122313122201000_314.7080.579.3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/clinids\/11.4.655","article-title":"Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain.","volume":"11","author":"Montalban","year":"1989","journal-title":"Rev Infect Dis"},{"key":"2025122313122201000_314.7080.579.4","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jama.1996.03530410043031","article-title":"Survival from early, intermediate, and late stages of HIV infection.","volume":"275","author":"Enger","year":"1996","journal-title":"JAMA"},{"key":"2025122313122201000_314.7080.579.5","unstructured":"Jones JL Hanson DL Ward JW Kaplan JE .Incidence trends in AIDS-related opportunistic illnesses in injecting drug users and men who have sex with men. XI International Conference on AIDS,Vancouver,1996. (Abstract WeC2418.)"},{"key":"2025122313122201000_314.7080.579.6","unstructured":"Dore G Kaldor J Hoy J Mallal S Li Y Mijch M .Trends in AIDS-related illness in Australia: the Australian AIDS Cohort. XI International Conference on AIDS,Vancouver,1996. (Abstract TuB2236.)"},{"key":"2025122313122201000_314.7080.579.7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/0003-4819-124-7-199604010-00003","article-title":"Natural history of opportunistic disease in an HIV-infected urban clinical cohort.","volume":"124","author":"Moore","year":"1996","journal-title":"Ann Intern Med"},{"key":"2025122313122201000_314.7080.579.8","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/clinids\/21.Supplement_1.S32","article-title":"USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations.","volume":"21","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2025122313122201000_314.7080.579.9","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/infdis\/165.6.1082","article-title":"Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients.","volume":"165","author":"Nightingale","year":"1992","journal-title":"J Infect Dis"},{"key":"2025122313122201000_314.7080.579.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309163291202"},{"key":"2025122313122201000_314.7080.579.11","unstructured":"Oldfield EC Dickinson G Chung R Wallace MR Craig DB Fessel WJ .Once weekly azithromycin for the prevention of Mycobacterium avium complex (MAC) infection in AIDS patients. Third Conference on Retroviruses and Opportunistic Infections,Washington, DC,1996. (Abstract 203.)"},{"key":"2025122313122201000_314.7080.579.12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1056\/NEJM199608083350603","article-title":"A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.","volume":"335","author":"Pierce","year":"1996","journal-title":"N Engl J Med"},{"key":"2025122313122201000_314.7080.579.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608083350604"},{"key":"2025122313122201000_314.7080.579.14","unstructured":"Cohn DL Benson CA Williams P Nevin T Korvick J Hafner R .A prospective, randomized, double-blind, comparative study of the safety and efficacy of clarithromycin vs. rifabutin vs. the combination for the prevention of Mycobacterium avium complex (MAC) bacteremia or disseminated MAC disease in HIV-infected patients with CD4 counts<100 cells\/mm3. XI International Conference on AIDS,Vancouver,1996. (Abstract WeB421.)"},{"key":"2025122313122201000_314.7080.579.15","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/00002030-199512000-00006","article-title":"Survival analysis of two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex in AIDS.","volume":"9","author":"Moore","year":"1995","journal-title":"AIDS"},{"key":"2025122313122201000_314.7080.579.16","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.4.685"},{"key":"2025122313122201000_314.7080.579.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608083350602"},{"key":"2025122313122201000_314.7080.579.18","unstructured":"May T Vincent V Brel F Beuscart CL Perronne C Doco Lecompte T .The French randomized clinical trial of combination therapy with clarithromycin for MAC bacteremia in AIDS patients: final results. XI International Conference on AIDS,Vancouver,1996. (Abstract WeB422.)"},{"key":"2025122313122201000_314.7080.579.19","unstructured":"Dub\u00e9 M Sattler F Torriani F See D Havlir D Kemper C .Prevention of relapse of MAC bacteremia in AIDS: a randomized study of clarithromycin plus clofazimine, with or without ethambutol. Third Conference on Retroviruses and Opportunistic Infections,Washington, DC,1996. (Abstract 206.)"},{"key":"2025122313122201000_314.7080.579.20","doi-asserted-by":"crossref","unstructured":"Chaisson RE Keiser P Pierce M Fessel WJ Ruskin J Lahart C Meek K .Controlled trial of clarithromycin\/ethambutol with or without clofazimine for Mycobacterium avium complex bacteremia in AIDS. Third Conference on Retroviruses and Opportunistic Infections,Washington, DC,1996.","DOI":"10.1097\/00002030-199703110-00008"},{"key":"2025122313122201000_314.7080.579.21","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJM199312233292604","article-title":"Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.","volume":"329","author":"Hoover","year":"1993","journal-title":"N Engl J Med"},{"key":"2025122313122201000_314.7080.579.22","first-page":"213","article-title":"Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.","volume":"326","year":"1992","journal-title":"N Engl J Med"},{"key":"2025122313122201000_314.7080.579.23","first-page":"471","article-title":"The Oral Ganciclovir European and Australian Cooperative Study Group.","volume":"9","year":"1995","journal-title":"AIDS"},{"key":"2025122313122201000_314.7080.579.24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJM199509073331002","article-title":"Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS.","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"2025122313122201000_314.7080.579.25","unstructured":"Squires KE Stempien MJ Shadman A Buhles WC .Oral ganciclovir versus intravenous ganciclovir maintenance therapy for cytomegalovirus retinitis in patients with AIDS: preliminary results of a phase III study. First National Conference on Human Retroviruses and Related Infections,Washington, DC,1993. (Abstract 540.)"},{"key":"2025122313122201000_314.7080.579.26","unstructured":"Lalezari J Friedberg D Bisset J Giordano M Hardy D Robinson C .A comparison of the safety and efficacy of 3 g, 4.5 g, and 6 g doses of oral ganciclovir versus IV ganciclovir for maintenance treatment of CMV retinitis. XI International Conference on AIDS,Vancouver,1996. (Abstract ThB305.)"},{"key":"2025122313122201000_314.7080.579.27","unstructured":"Kupperman B Lalezari J Stagg R Kramer F Holland G Ives D .A phase II\/III randomized study of immediate versus deferred intravenous cidofovir for AIDS patients with peripheral CMV retinitis. International Symposium on Experimental and Clinical Ocular Pharmacology and Pharmaceutics,Geneva,1995."},{"key":"2025122313122201000_314.7080.579.28","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1992.01080140044023"},{"key":"2025122313122201000_314.7080.579.29","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archopht.1994.01090240037023","article-title":"Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.","volume":"112","author":"Martin","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"2025122313122201000_314.7080.579.30","unstructured":"Chiron ganciclovir implant study group .A randomized controlled multicenter clinical trial of a sustained-release intraocular ganciclovir implant in AIDS patients with CMV retinitis. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy,San Francisco,1995. (Abstract I215)."},{"key":"2025122313122201000_314.7080.579.31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.7326\/0003-4819-125-2-199607150-00003","article-title":"Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS.","volume":"125","author":"Rahhal","year":"1996","journal-title":"Ann Intern Med"},{"key":"2025122313122201000_314.7080.579.32","unstructured":"Lalezari JP Kemper C Stagg R Holland G Ives D Kramer F .A randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. XI International Conference on AIDS,Vancouver,1996. (Abstract ThB304.)"},{"key":"2025122313122201000_314.7080.579.33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archopht.1996.01100130021004","article-title":"The Cytomegalovirus Retreatment Trial.","volume":"114","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"2025122313122201000_314.7080.579.34","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJM199606063342302","article-title":"Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS.","volume":"334","author":"Spector","year":"1996","journal-title":"N Engl J Med"},{"key":"2025122313122201000_314.7080.579.35","unstructured":"Brosgart C Craig C Hillman D Louis TA Alston B Fisher E .Final results from a randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of CMV retinal and gastrointestinal mucosal disease. XI International Conference on AIDS,Vancouver,1996. (Abstract ThB301.)"},{"key":"2025122313122201000_314.7080.579.36","first-page":"126","article-title":"NIH Conference; H Masur, moderator.","volume":"125","year":"1996","journal-title":"Ann Intern Med"},{"key":"2025122313122201000_314.7080.579.37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503233321204"},{"key":"2025122313122201000_314.7080.579.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302253280801"},{"key":"2025122313122201000_314.7080.579.39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199507273330406","article-title":"Tuberculosis in New York City-turning the tide.","volume":"333","author":"Frieden","year":"1995","journal-title":"N Engl J Med"},{"key":"2025122313122201000_314.7080.579.40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJM199404283301702","article-title":"The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis.","volume":"330","author":"Weis","year":"1994","journal-title":"N Engl J Med"},{"key":"2025122313122201000_314.7080.579.41","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199302253280802","article-title":"Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.","volume":"328","author":"Goble","year":"1993","journal-title":"N Engl J Med"},{"key":"2025122313122201000_314.7080.579.42","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/clinids\/21.5.1238","article-title":"Improved outcomes for patients with multidrug-resistant tuberculosis.","volume":"21","author":"Turett","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2025122313122201000_314.7080.579.43","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/21.5.1245"},{"key":"2025122313122201000_314.7080.579.44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/jama.1996.03530280057037","article-title":"Transmission of tuberculosis among the urban homeless.","volume":"275","author":"Barnes","year":"1996","journal-title":"JAMA"},{"key":"2025122313122201000_314.7080.579.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406163302403"},{"key":"2025122313122201000_314.7080.579.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505043321801"},{"key":"2025122313122201000_314.7080.579.47","doi-asserted-by":"publisher","DOI":"10.1126\/science.7997879"},{"key":"2025122313122201000_314.7080.579.48","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1996.00440020112014"},{"key":"2025122313122201000_314.7080.579.49","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(95)91619-9","article-title":"Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.","volume":"346","author":"Whitby","year":"1995","journal-title":"Lancet"},{"key":"2025122313122201000_314.7080.579.50","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1056\/NEJM199605023341805","article-title":"Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen.","volume":"334","author":"Monini","year":"1996","journal-title":"N Engl J Med"},{"key":"2025122313122201000_314.7080.579.51","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJM199605163342003","article-title":"Antibodies to butyrate-inducible antigens of Kaposi's sarcoma- associated herpesvirus in patients with HIV-1 infection.","volume":"334","author":"Miller","year":"1996","journal-title":"N Engl J Med"},{"key":"2025122313122201000_314.7080.579.52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199607253350403","article-title":"Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.","volume":"335","author":"Gao","year":"1996","journal-title":"N Engl J Med"},{"key":"2025122313122201000_314.7080.579.53","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM199608013350501","article-title":"Changes in sexual behavior and decline in HIV infection among young men in Thailand.","volume":"335","author":"Nelson","year":"1996","journal-title":"N Engl J Med"},{"key":"2025122313122201000_314.7080.579.54","unstructured":"Robinson NJ Silarug N Surasiengsunk S Auvert B Hanenberg R .Two million HIV infections prevented in Thailand: estimate of the impact of increased condom use. XI International Conference on AIDS,Vancouver,1996. (Abstract MoC904.)"},{"key":"2025122313122201000_314.7080.579.55","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91380-7"},{"key":"2025122313122201000_314.7080.579.56","unstructured":"Wawer MJ Sewankambo NK Gray RH Serwadda D Paxton L Quinn TC .Community-based trial of mass STD treatment for HIV control, Rakai, Uganda: preliminary data on STD declines. XI International Conference on AIDS,Vancouver,1996. (Abstract MoC443.)"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.314.7080.579","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.314.7080.579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:12:30Z","timestamp":1766524350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.314.7080.579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2,22]]},"references-count":56,"journal-issue":{"issue":"7080","published-online":{"date-parts":[[1997,2,22]]},"published-print":{"date-parts":[[1997,2,22]]}},"alternative-id":["10.1136\/bmj.314.7080.579"],"URL":"https:\/\/doi.org\/10.1136\/bmj.314.7080.579","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"type":"print","value":"0959-8138"},{"type":"electronic","value":"1468-5833"}],"subject":[],"published":{"date-parts":[[1997,2,22]]}}}